on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Stake in Mural Oncology plc Revealed
The Vanguard Group, Inc. disclosed its position relating to Mural Oncology plc, in compliance with Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure, made on April 29, 2025, indicates Vanguard's ownership of 772,597 ordinary shares. This represents a 4.47% interest in Mural Oncology.
The report specifies that there were no dealings in cash or stock-settled derivatives connected to Mural Oncology. Additionally, Vanguard sold 18 shares at $2.61 each.
No indemnity or derivative agreements related to Mural were reported by Vanguard. The disclosure further clarifies that no supplemental forms accompany this statement.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news